United Guardian (UG) Change in Receivables (2010 - 2026)
United Guardian's (UG) quarterly Change in Receivables came in at -$317340.0 in Q2 2026, down 188.41% year-over-year from $358929.0 in Q2 2025, and down 174.6% quarter-over-quarter from $425371.0 in Q1 2026.
Powered by 
Analysis
United Guardian (UG) Change in Receivables (2010 - 2026) Analysis & Trends
United Guardian has disclosed Change in Receivables across 17 years of filings, most recently posting -$317340.0 for Q2 2026.
- In Q2 2026, Change in Receivables fell 188.41% year-over-year to -$317340.0; the TTM figure through Jun 2026 stood at -$217033.0 (down 193.58% YoY), while the FY2025 annual figure was $161261.0, up 214.6% from the prior year.
- Change in Receivables came in at -$317340.0 for Q2 2026 at United Guardian, down from $425371.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $744279.0 in Q1 2022 to a low of -$989524.0 in Q3 2022.
- Average Change in Receivables over 5 years is -$6750.5, with a median of $63702.5 recorded in 2023.
- Year-over-year, Change in Receivables sank 3068.4% in 2022 and soared 981.32% in 2024.
- Over 5 years, Change in Receivables stood at $302228.0 in 2022, then slumped by 186.47% to -$261344.0 in 2023, then soared by 73.01% to -$70544.0 in 2024, then soared by 707.09% to $428263.0 in 2025, then tumbled by 174.1% to -$317340.0 in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were -$317340.0 in Q2 2026, $425371.0 in Q1 2026, and $428263.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.54 Bn | 626.78 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 441.45 Bn | 434.88 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 364.78 Bn | 357.64 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.01 Bn | 259.32 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.54 Bn | 45.16 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | - |
| 8 | Incyte | 25.36 Bn | 20.82 Bn | 1.57 Bn | 73.80 Mn |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn | -1.70 Mn |
| 10 | United Guardian | 32.95 Mn | 23.36 Mn | 1.55 Mn | -317,340.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -317,340.00 |
| Mar 31, 2026 | 425,371.00 |
| Dec 31, 2025 | 428,263.00 |
| Sep 30, 2025 | -753,327.00 |
| Jun 30, 2025 | 358,929.00 |
| Mar 31, 2025 | 127,396.00 |
| Dec 31, 2024 | -70,544.00 |
| Sep 30, 2024 | -183,857.00 |
| Jun 30, 2024 | -460,254.00 |
| Mar 31, 2024 | 573,941.00 |
| Dec 31, 2023 | -261,344.00 |
| Sep 30, 2023 | 269,811.00 |
| Jun 30, 2023 | 74,327.00 |
| Mar 31, 2023 | 53,078.00 |
| Dec 31, 2022 | 302,228.00 |
| Sep 30, 2022 | -989,524.00 |
| Jun 30, 2022 | -442,942.00 |
| Mar 31, 2022 | 744,279.00 |
| Dec 31, 2021 | -123,881.00 |
| Sep 30, 2021 | -31,231.00 |